These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 31828903)
1. Correlations between blood lipid, serum cystatin C, and homocysteine levels in patients with Parkinson's disease. Li J; Gu C; Zhu M; Li D; Chen L; Zhu X Psychogeriatrics; 2020 Mar; 20(2):180-188. PubMed ID: 31828903 [TBL] [Abstract][Full Text] [Related]
2. A retrospective study of Parkinson's disease in Southwest China 2021-2024: An age-based approach. Chen C; Zhang D; Chen F; Wu D; Chen W; Qin H; Hu Y Exp Gerontol; 2024 Oct; 195():112532. PubMed ID: 39068693 [TBL] [Abstract][Full Text] [Related]
3. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370 [TBL] [Abstract][Full Text] [Related]
4. Correlation of serum homocysteine and cystatin C levels with prognosis in heart failure with preserved ejection fraction patients. Chen ZH; Zhu XT; Hu ZP; Ni JX; Chen HL BMC Cardiovasc Disord; 2024 Sep; 24(1):510. PubMed ID: 39327565 [TBL] [Abstract][Full Text] [Related]
5. Measurement of serum cystatin C: A valuable tool for evaluating dyskinesia in Parkinson's disease. Dong X; Zheng D; Nao J Neurosci Lett; 2019 Jul; 705():172-176. PubMed ID: 31054924 [TBL] [Abstract][Full Text] [Related]
6. Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital. Ojo OO; Oladipo OO; Ojini FI; Sanya EO; Danesi MA; Okubadejo NU West Afr J Med; 2011; 30(5):319-24. PubMed ID: 22752818 [TBL] [Abstract][Full Text] [Related]
8. Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. Ozkan Y; Ozkan E; Simşek B Int J Cardiol; 2002 Mar; 82(3):269-77. PubMed ID: 11911915 [TBL] [Abstract][Full Text] [Related]
9. [Preliminary relationship between serum cystatin C level and Parkinson's disease]. Xu J; Chen J; Mao C; Yang Y; Liu C Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(11):804-7. PubMed ID: 24854744 [TBL] [Abstract][Full Text] [Related]
10. Homocysteine diminishes apolipoprotein A-I function and expression in patients with hypothyroidism: a cross-sectional study. Yang N; Yao Z; Miao L; Liu J; Gao X; Xu Y; Wang G Lipids Health Dis; 2016 Jul; 15():123. PubMed ID: 27457726 [TBL] [Abstract][Full Text] [Related]
11. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease. Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010 [TBL] [Abstract][Full Text] [Related]
12. The expression features of serum Cystatin C and homocysteine of Parkinson's disease with mild cognitive dysfunction. Chen WW; Cheng X; Zhang X; Zhang QS; Sun HQ; Huang WJ; Xie ZY Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):2957-63. PubMed ID: 26367713 [TBL] [Abstract][Full Text] [Related]
13. Decreased Serum Lipid Levels and Ratios Correlate with Low Prevalence of Coronary Heart Disease in Patients with Parkinson's Disease. Bao M; Hu R; Chen Y; Wang N; Xue H; He J; Jin J; Kong W; Ke G; Xue Q Clin Lab; 2018 Sep; 64(9):1413-1419. PubMed ID: 30274018 [TBL] [Abstract][Full Text] [Related]
14. Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients. Camicioli RM; Bouchard TP; Somerville MJ Mov Disord; 2009 Jan; 24(2):176-82. PubMed ID: 18951534 [TBL] [Abstract][Full Text] [Related]
15. Correlations of degree of coronary artery stenosis with blood lipid, CRP, Hcy, GGT, SCD36 and fibrinogen levels in elderly patients with coronary heart disease. Han K; Lu Q; Zhu WJ; Wang TZ; Du Y; Bai L Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9582-9589. PubMed ID: 31773710 [TBL] [Abstract][Full Text] [Related]
16. Homocysteine Levels in Parkinson's Disease: Is Entacapone Effective? Kocer B; Guven H; Comoglu SS Biomed Res Int; 2016; 2016():7563705. PubMed ID: 27493964 [TBL] [Abstract][Full Text] [Related]
17. Correlation among cystatin C, homocysteine and arteriosclerosis indexes in patients with chronic kidney disease. Chen T; Li Y; Wang J; Wang J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1338-1345. PubMed ID: 35232902 [TBL] [Abstract][Full Text] [Related]
18. The relationships of serum homocysteine levels and traditional lipid indicators with disease activity and coronary artery involvement in Takayasu arteritis. Chen S; Luan H; He J; Wang Y; Zeng X; Li Y; Yuan H Immunol Res; 2020 Dec; 68(6):405-413. PubMed ID: 33064263 [TBL] [Abstract][Full Text] [Related]
19. Effects of rasagiline combined with levodopa and benserazide hydrochloride on motor function and homocysteine and IGF-1 levels in elderly patients with Parkinson's disease. Yang Y; Gao F; Gao L; Miao J BMC Neurol; 2023 Oct; 23(1):360. PubMed ID: 37803329 [TBL] [Abstract][Full Text] [Related]
20. New atherosclerosis risk factors in obese, hypertensive and diabetic children and adolescents. Glowinska B; Urban M; Koput A; Galar M Atherosclerosis; 2003 Apr; 167(2):275-86. PubMed ID: 12818410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]